{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:46:17Z","timestamp":1785509177688,"version":"3.56.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Anti-OJ antibody is relatively rarely detected in patients with the anti-synthetase syndrome, which is polymyositis (PM)\/dermatomyositis (DM) with anti-aminoacyl transfer ribonucleic acid (RNA) synthetase antibodies. There have been few case reports of anti-OJ antibody-positive PM\/DM complicated by other connective tissue disorders. Herein, we report the case of a 33-year-old woman who was admitted to our hospital with fever, muscle weakness, and dyspnoea on exertion. She was diagnosed with anti-OJ antibody-positive PM, overlapping systemic lupus erythematosus, and Sj\u00f6gren\u2019s syndrome (SS). Her symptoms and clinical findings improved after treatment with prednisolone 1\u2009mg\/kg\/day without immunosuppressive agents. This is the first case of overlap syndrome with anti-OJ antibody-positive PM, systemic lupus erythematosus, and Sj\u00f6gren\u2019s syndrome.<\/jats:p>","DOI":"10.1093\/mrcr\/rxac087","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T12:07:53Z","timestamp":1669378073000},"page":"399-403","source":"Crossref","is-referenced-by-count":4,"title":["Overlap syndrome involving anti-OJ antibody-positive polymyositis, systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome: A case report and literature review"],"prefix":"10.1093","volume":"7","author":[{"given":"Yumiko","family":"Mizuhashi","sequence":"first","affiliation":[{"name":"Department of Hematology, Rheumatology, and Infectious Diseases, Kumamoto University , Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology, and Infectious Diseases, Kumamoto University , Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komei","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology, and Infectious Diseases, Kumamoto University , Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology, and Infectious Diseases, Kumamoto University , Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Iwakura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology, and Infectious Diseases, Kumamoto University , Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology, and Infectious Diseases, Kumamoto University , Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Sasai","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Kyoto University Hospital , Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology, and Infectious Diseases, Kumamoto University , Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"2023061920012484200_R1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/25785826.2018.1531188","article-title":"Clinical significance of myositis-specific autoantibodies","volume":"41","author":"Nakashima","year":"2018","journal-title":"Immunol Med"},{"key":"2023061920012484200_R2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/jcm8112013","article-title":"Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course","volume":"8","author":"Cavagna","year":"2019","journal-title":"J Clin Med"},{"key":"2023061920012484200_R3","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023061920012484200_R4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/s10165-004-0338-x","article-title":"Revised Japanese criteria for Sj\u00f6gren\u2019s syndrome (1999): availability and validity","volume":"14","author":"Fujibayashi","year":"2004","journal-title":"Mod Rheumatol"},{"key":"2023061920012484200_R5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2023061920012484200_R6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel435","article-title":"Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies","volume":"46","author":"Sato","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2023061920012484200_R7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal muscle involvement in antisynthetase syndrome","volume":"74","author":"Noguchi","year":"2017","journal-title":"JAMA Neurol"},{"key":"2023061920012484200_R8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLOS ONE"},{"key":"2023061920012484200_R9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/rheumatology\/ker132","article-title":"Anti-synthetase syndrome positive for anti-isoleucyl-tRNA synthetase antibodies: an unusual case overlapping with systemic sclerosis and Sjogren\u2019s syndrome","volume":"50","author":"Hervier","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2023061920012484200_R10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies","volume":"49","author":"Koreeda","year":"2010","journal-title":"Intern Med"},{"key":"2023061920012484200_R11","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00296-010-1695-8","article-title":"Dermatomyositis with anti-OJ antibody","volume":"31","author":"Noda","year":"2011","journal-title":"Rheumatol Int"},{"key":"2023061920012484200_R12","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2169\/internalmedicine.51.7452","article-title":"The clinical characteristics of two anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody-positive interstitial lung disease patients with polymyositis\/dermatomyositis","volume":"51","author":"Kunimasa","year":"2012","journal-title":"Intern Med"},{"key":"2023061920012484200_R13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5152\/eurjrheum.2018.17167","article-title":"Novel case of anti-synthetase syndrome","volume":"5","author":"Kapoor","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"2023061920012484200_R14","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.rmed.2014.09.003","article-title":"Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type","volume":"108","author":"Johnson","year":"2014","journal-title":"Respir Med"},{"key":"2023061920012484200_R15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/14397595.2015.1014137","article-title":"Juvenile polymyositis associated with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody in a 13-year-old girl","volume":"27","author":"Hamada","year":"2017","journal-title":"Mod Rheumatol"},{"key":"2023061920012484200_R16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients","volume":"73","author":"Aggarwal","year":"2014","journal-title":"Ann Rheum Dis"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxac087\/47997958\/rxac087.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/7\/2\/399\/50646548\/rxac087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/7\/2\/399\/50646548\/rxac087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T20:05:50Z","timestamp":1687205150000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/7\/2\/399\/6845836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,11,25]]},"published-print":{"date-parts":[[2023,6,19]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxac087","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2022,11,25]]}}}